Factors Influencing Recurrence Following Anatomic Lung Resection for Clinical Stage I Non-Small Cell Lung Cancer

Lung cancer is the most common cause of cancer-related death world-wide, with approximately 1,378,400 deaths reported annually. Deaths due to lung cancer exceed those of breast, prostate, and colorectal carcinoma combined, creating catastrophic health care and economic implications [1,2]. Complete resection, when possible, remains the mainstay of therapy, and affords patients the best chance of long-term survival [3,4]. Not all patients undergoing resection are destined for cure, with recurrence rates in early-stage disease (clinical stage I) ranging from 20-40% at five years [5].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research